PMID: 8607738Feb 1, 1996Paper

Behavioral management of conversion disorder: retrospective study

Archives of Physical Medicine and Rehabilitation
J Speed

Abstract

To assess whether operant behavioral treatment of conversion disorder provides effective and durable symptom resolution, and to evaluate the prognostic value of duration of symptoms, as to the time required to effect symptom resolution. Retrospective case series (consecutive sample). Inpatient rehabilitation unit in a tertiary care center. The first 10 patients with conversion disorder treated by the author. There were 5 men and 5 women, age range 19 to 69 years, mean 32.7 years. The duration of conversion disorder symptoms (all involving gait) ranged from 0.5 to more than 112 weeks (mean 27.8 weeks, median 12 weeks). Follow-up range was 7 to 36 months (mean 20 months). All patients were treated as inpatients using a behavioral approach. A 'pseudo-scientific' explanation of the symptoms was provided, with an explanation that stressors can exacerbate symptoms. patients were in a wheelchair when no in therapy, and a physical therapy program was devised, using a treatment sequence based treatment of the analogous neurological condition. Other therapies were also utilized for positive reinforcement of normal function. All patients had psychological evaluation, with treatment as indicated. Patients were hospitalized long enough to r...Continue Reading

References

Feb 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·J Bird
Feb 1, 1989·Archives of Neurology·F O WalkerW T McLean
Jun 28, 1986·British Medical Journal·M A DelargyA A Burt
Oct 1, 1986·The Journal of Nervous and Mental Disease·R GouldD F Benson
May 1, 1969·Behaviour Research and Therapy·I Liebson
Jun 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·H B Hafeiz

❮ Previous
Next ❯

Citations

Aug 10, 2002·The Journal of Trauma·Pradeep Matthew PoonnooseMartin Raymond McClelland
Apr 11, 2007·Journal of Neurologic Physical Therapy : JNPT·Debra Ness
Apr 30, 2003·Archives of Disease in Childhood·P Calvert, J Jureidini
Oct 14, 2009·Indian Journal of Psychiatry·Chittaranjan AndradeNagendra M Singh
Aug 7, 2013·Journal of Psychosomatic Research·Glenn NielsenMark J Edwards
Feb 3, 2006·International Review of Psychiatry·Miyako Tazaki, Kenneth Landlaw
Nov 18, 2006·The Kaohsiung Journal of Medical Sciences·Hsien-Yeh ChouTien-Wen Chen
Jan 22, 2013·PM & R : the Journal of Injury, Function, and Rehabilitation·Samantha L KanarekJo Ann Brockway
May 1, 2012·PM & R : the Journal of Injury, Function, and Rehabilitation·Kristi L KirschnerRichard A A Kanaan
Jun 27, 2009·Neurologic Clinics·Elizabeth L Peckham, Mark Hallett
Mar 19, 2008·Dermatologic Clinics·Pearl Sherienne C Legaspi, Maria Luisa Abad Venida
Mar 11, 2008·Clinical Psychology Review·Warren W Tryon
Aug 28, 2007·Epilepsy & Behavior : E&B·Jayne L BrooksGus A Baker
Oct 4, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew McKeonJoseph Y Matsumoto
Mar 1, 1997·Archives of Physical Medicine and Rehabilitation·J L GoochJ Speed
Nov 30, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Glenn NielsenMark Edwards
Jul 20, 2005·Heart & Lung : the Journal of Critical Care·Sanjeev SockalingamShree Bhalerao
Jun 18, 1998·Archives of Physical Medicine and Rehabilitation·T K WatanabeT J Togliatti
Oct 20, 2005·The Cochrane Database of Systematic Reviews·R Ruddy, A House
Mar 20, 2018·PM & R : the Journal of Injury, Function, and Rehabilitation·Ashlee BolgerDavid Pruitt
Jan 5, 2019·PM & R : the Journal of Injury, Function, and Rehabilitation·Abigail S Hardin, Cody Carson
Jan 6, 2007·Scandinavian Journal of Occupational Therapy·A Birgitta GunnarssonMona Eklund
Aug 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Allan P Shapiro, Robert W Teasell
Nov 2, 2012·Journal of Korean Neurosurgical Society·Han-Il LeeYoung-Baeg Kim
Oct 15, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Ruaidhri McCormackAnthony S David
Jun 27, 2017·Harvard Review of Psychiatry·Christopher D StephenDavid L Perez
Jul 19, 2020·The Cochrane Database of Systematic Reviews·Christina A GanslevUlf Søgaard
Oct 26, 2005·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Duck Won OhOh Yun Kwon
Jun 8, 2015·Journal of Pediatric Orthopedics. Part B·Tadahiro HiguchiKoichi Sairyo
Aug 4, 2020·Journal of Clinical Psychology in Medical Settings·Karen E WeissAaron D Fobian
Jul 22, 2020·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Gabriela S Gilmour, Jessica D Jenkins
Feb 23, 2021·Frontiers in Neurology·Lucy FruchtChristopher D Stephen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Physical Medicine and Rehabilitation
J L GoochJ Speed
Journal of Neurologic Physical Therapy : JNPT
Debra Ness
Archives of Physical Medicine and Rehabilitation
D D CardenasK J Egan
Journal of Neurology, Neurosurgery, and Psychiatry
W CouprieJ van Gijn
© 2021 Meta ULC. All rights reserved